Search by Drug Name or NDC

    NDC 41250-0768-36 Meijer Effervescent Cold Relief 325; 2; 7.8 mg/1; mg/1; mg/1 Details

    Meijer Effervescent Cold Relief 325; 2; 7.8 mg/1; mg/1; mg/1

    Meijer Effervescent Cold Relief is a ORAL TABLET, EFFERVESCENT in the HUMAN OTC DRUG category. It is labeled and distributed by Meijer Distribution Inc.. The primary component is ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE.

    Product Information

    NDC 41250-0768
    Product ID 41250-768_c1337938-3512-5756-e053-2a95a90adcf5
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Meijer Effervescent Cold Relief
    Proprietary Name Suffix n/a
    Non-Proprietary Name Aspirin, Chlorpheniramine Maleate, Phenylephrine Bitartrate
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, EFFERVESCENT
    Route ORAL
    Active Ingredient Strength 325; 2; 7.8
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE
    Labeler Name Meijer Distribution Inc.
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor An
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 41250-0768-36 (41250076836)

    NDC Package Code 41250-768-36
    Billing NDC 41250076836
    Package 18 POUCH in 1 CARTON (41250-768-36) / 2 TABLET, EFFERVESCENT in 1 POUCH
    Marketing Start Date 2014-03-07
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 6933ca9d-a32d-d856-e053-2a91aa0a408e Details

    Revised: 4/2021